Education
About Us
Working with TipRanks
Follow Us
Allogene Therapeutics (ALLO)
:ALLO
Allogene Therapeutics (ALLO) Ownership Overview
10.76% Insiders
20.45% Mutual Funds
0.98% Other Institutional Investors
8.08% ETFs
59.73% Public Companies and
Individual Investors
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail, and individual investors. Approximately 29.51% of the company’s stock is owned by Institutional Investors, 10.76% is owned by Insiders, and 59.73% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 10, 2024 | xxxxxxxxxxxxx | $19916 | |
Dec 09, 2024 | xxxxxxxxxxxxx | $19917 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $6366487 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $7200486 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,265,330 | Institution | 5.61% | 15,086,356 | |
| 11,009,103 | Insider | 5.03% | 13,541,197 | |
| 8,189,765 | Insider | 3.74% | 10,073,411 | |
| 7,829,457 | Institution | 3.58% | 9,630,232 | |
| 6,637,353 | Institution | 3.03% | 8,163,944 | |
| 6,571,471 | Institution | 3.00% | 8,082,909 | |
| 4,931,840 | Institution | 2.25% | 6,066,163 | |
| 4,360,608 | Institution | 1.99% | 5,363,548 | |
| 3,265,529 | Institution | 1.49% | 4,016,601 | |
| 2,964,570 | Institution | 1.36% | 3,646,421 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,265,330 | Institution | 5.61% | 15,086,356 | |
| 6,637,353 | Institution | 3.03% | 8,163,944 | |
| 3,265,529 | Institution | 1.49% | 4,016,601 | |
| 2,964,570 | Institution | 1.36% | 3,646,421 | |
| 2,936,094 | Institution | 1.34% | 3,611,396 | |
| 2,214,584 | Institution | 1.01% | 2,723,938 | |
| 1,785,270 | Institution | 0.82% | 2,195,882 | |
| 1,741,870 | Institution | 0.80% | 2,142,500 | |
| 1,472,660 | Institution | 0.67% | 1,811,372 | |
| 1,461,875 | Institution | 0.67% | 1,798,106 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,278,056 | Institution | 1.96% | 4,834,203 | |
| 3,772,870 | Institution | 1.72% | 4,678,359 | |
| 2,358,985 | Institution | 1.08% | 2,665,653 | |
| 1,301,469 | Institution | 0.60% | 1,613,822 | |
| 900,619 | Institution | 0.41% | 1,116,768 | |
| 786,261 | Institution | 0.36% | 1,014,277 | |
| 771,877 | Institution | 0.35% | 872,221 | |
| 459,330 | Institution | 0.21% | 519,043 | |
| 410,272 | Institution | 0.19% | 529,251 | |
| 399,725 | Institution | 0.18% | 515,645 |
FAQ
Who Owns Allogene Therapeutics (ALLO)?
According to the latest TipRanks data, approximately 0.98% of the company's stock is held by institutional investors, 10.76% is held by insiders, and 59.73% is held by retail investors.
What percentage of Allogene Therapeutics (ALLO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.98% of Allogene Therapeutics (ALLO) stock is held by institutional investors.
What percentage of Allogene Therapeutics (ALLO) stock is held by retail investors?
According to the latest TipRanks data, approximately 59.73% of Allogene Therapeutics (ALLO) stock is held by retail investors.
Who owns the most shares of Allogene Therapeutics (ALLO)?
SMALLCAP World Fund Inc owns the most shares of Allogene Therapeutics (ALLO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.